Cargando...
Drug tendering: drug supply and shortage implications for the uptake of biosimilars
Due to the continued increase in global spending on health care, payers have introduced a number of programs, policies, and agreements on pharmaceutical pricing in order to control costs. While incentives to increase generic drug use have achieved significant savings, other cost-containment measures...
Guardado en:
| Publicado en: | Clinicoecon Outcomes Res |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5628685/ https://ncbi.nlm.nih.gov/pubmed/29033595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S140063 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|